Your browser doesn't support javascript.
loading
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII.
Hillarp, Andreas; Holme, Pål A; Wåland, Erik P; Le, Marie S; Henriksson, Carola E; Tjønnfjord, Geir E; Måseide, Ragnhild J.
Afiliação
  • Hillarp A; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Department of Translational Medicine, Lund University, Lund, Sweden.
  • Holme PA; Department of Haematology, Oslo University Hospital, Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Wåland EP; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Le MS; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
  • Henriksson CE; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Måseide RJ; Department of Haematology, Oslo University Hospital, Oslo, Norway. Electronic address: ragmas@ous-hf.no.
J Thromb Haemost ; 21(10): 2771-2775, 2023 10.
Article em En | MEDLINE | ID: mdl-37543216
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Diagnostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Diagnostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article